GeneMatrix Inc. (KOSDAQ:109820)
South Korea · Delayed Price · Currency is KRW 1,402.00
+21.00 (1.52%)
At close: Jul 21, 2026
GeneMatrix Market Cap
GeneMatrix has a market cap or net worth of 28.59 billion as of July 21, 2026. Its market cap has decreased by -48.07% in one year.
Market Cap
28.59B
Enterprise Value
n/a
Revenue
4.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,402.00
ChartMarket Cap Chart
Since November 6, 2009, GeneMatrix's market cap has decreased from 33.85B to 28.59B, a decrease of -15.53%. That is a compound annual growth rate of -1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 28.59B | -42.89% |
| Dec 30, 2025 | 50.07B | -9.74% |
| Dec 30, 2024 | 55.47B | -12.40% |
| Dec 28, 2023 | 63.32B | -23.43% |
| Dec 29, 2022 | 82.69B | -58.54% |
| Dec 30, 2021 | 199.45B | -62.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 187.75B |
| GENINUS | 89.62B |
| Cytogen | 70.36B |
| Inventera | 60.33B |
| Protia | 60.28B |
| GC Medical Science | 59.79B |
| HLB Panagene | 54.95B |
| Seoulin Bioscience | 40.05B |